05.13.24 -- Stop Fixating On CDMO Pricing!

Join us on May 13th as our expert panel discusses the intricacies of technology transfer, drawing from real-life case studies. Investigate critical components for success, risk assessment, and effective mitigation strategies. Learn how to optimize your timeline and enhance efficiency in your transfer processes. Click here to learn more.

The oncology pharma market has largely been dominated by European and U.S. companies. With the ongoing expansion of the Chinese biopharma sector, innovative oncology drugs will emerge from China and compete on the international market.

Discover how a CDMO partner that addresses challenges in CHO cell line development and implements efficient and reliable solutions can enable the efficient production of biopharmaceuticals.

Learn about formulation development challenges for prefilled syringes as well as considerations for reducing the time it takes to launch safer, more convenient, and cost-effective products for the patient.

Automated manufacturing is a powerful but often misunderstood tool available to produce drug delivery and other pharmaceutical devices — whether established designs or innovative new ideas.

Review the different technologies that are being used to develop next-generation vaccines and the challenges and opportunities that these technologies present.

As sponsors strive to deliver therapies with increasing efficiency, CDMOs are poised to remain vital, offering expertise, accelerated timelines, cost efficiency, and risk mitigation.

Explore how to approach the transition of migrating from a vial to a syringe or cartridge, the necessary compatibility testing, and the stresses on the bulk product during formulation and filling.

Understanding the obstacles you may face during bioconjugate development, as well as the tools available to help overcome them, can streamline your path to market.

Introducing our new Fill/Finish session! Outsourced Pharma Capacity Update’s new PARTNER WEEK offers an extended schedule and sessions grouped by capability including a day featuring the latest sterile filling, lyophilization, and advanced packaging technologies from CDMOs with current capacity for your manufacturing demands. Secure your spot for this session happening May 20th.

Our modular approach to next-gen vaccine manufacturing integrates novel biological, analytical, or process-related technologies that can leapfrog the industry forward.

Outsourcing to a CTDMO is a promising solution for companies lacking the technical expertise and in-house capacity to address biomanufacturing challenges. Learn why selecting the right CTDMO partner is vital for project success.

Simtra currently has open capacity for liquid vial projects at both manufacturing sites and can support rapid tech transfer depending on the complexity of the project and the availability of materials.

Utilizing Singota's International SCM services involves cost savings, risk mitigation, logistics support, and streamlined communication.